ONCOCYTE CORP (OCX) Forecast, Price Target & Analyst Ratings

NASDAQ:OCX • US68235C2061

Current stock price

3.2 USD
+0.47 (+17.22%)
At close:
3.17 USD
-0.03 (-0.94%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ONCOCYTE CORP (OCX).

Forecast Snapshot

Consensus Price Target

Price Target
$5.53
+ 72.66% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Aug 6, 2025
Period
Q2 / 2025
EPS Estimate
-$0.23
Revenue Estimate
174.397K
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
75.00%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$5.53
Upside
+ 72.66%
From current price of $3.20 to mean target of $5.53, Based on 8 analyst forecasts
Low
$4.04
Median
$4.34
High
$8.40

Price Target Revisions

1 Month
20.37%
3 Months
31.31%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for OCX. The average price target is 5.53 USD. This implies a price increase of 72.66% is expected in the next year compared to the current price of 3.2.
The average price target has been revised upward by 31.31% in the past 3 months.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

OCX Current Analyst RatingOCX Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 0 0 0 0 0

Analyst Ratings History

OCX Historical Analyst RatingsOCX Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -19 -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
75.00%
OCX was analyzed by 8 analysts. The buy percentage consensus is at 75. So analysts seem to be have mildly positive about OCX.
In the previous month the buy percentage consensus was at a similar level.
OCX was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2025-05-21Lake StreetMaintains Buy -> Buy
2025-05-13NeedhamReiterate Buy -> Buy
2025-04-08NeedhamReiterate Buy -> Buy
2025-03-28Lake StreetInitiate Buy
2025-03-26Stephens & Co.Reiterate Equal-Weight -> Equal-Weight
2025-03-25NeedhamReiterate Buy -> Buy
2025-03-25Stephens & Co.Reiterate Equal-Weight -> Equal-Weight
2024-11-13NeedhamReiterate Buy -> Buy
2024-10-15NeedhamReiterate Buy -> Buy
2024-08-09NeedhamReiterate Buy -> Buy
2024-05-16NeedhamReiterate Buy -> Buy
2024-04-24NeedhamMaintains Buy -> Buy
2024-04-17Stephens & Co.Reiterate Equal-Weight -> Equal-Weight
2024-04-15BenchmarkReiterate Speculative Buy -> Speculative Buy
2023-11-13Piper SandlerMaintains Neutral -> Neutral
2023-11-09NeedhamMaintains Buy -> Buy
2023-08-24BenchmarkMaintains Speculative Buy -> Speculative Buy
2023-08-15Piper SandlerMaintains Neutral -> Neutral
2023-08-10NeedhamMaintains Buy -> Buy
2023-04-04NeedhamMaintains Buy
2022-12-01Lake StreetDowngrade Buy -> Hold
2022-11-18Piper SandlerDowngrade Overweight -> Neutral
2022-11-14Piper SandlerMaintains Overweight
2022-11-11NeedhamMaintains Buy
2022-08-17Piper SandlerMaintains Overweight

Next Earnings Forecast Details

Next Earnings Details

Release Date
Aug 6, 2025
Period
Q2 / 2025
EPS Estimate
-$0.23
Revenue Estimate
174.397K
Revenue Q2Q
67.69%
EPS Q2Q
35.47%
Number of Analysts
5

Next Earnings Revisions

Revenue (1 Month)
0.00%
Revenue (3 Months)
2.17%
EPS (1 Month)
0.00%
EPS (3 Months)
26.05%

Next Earnings Summary

OCX is expected to report earnings on 8/6/2025. The consensus EPS estimate for the next earnings is -0.23 USD and the consensus revenue estimate is 174.40K USD.
The next earnings revenue estimate has been revised upward by 2.17% in the past 3 months.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2022 2023 2024 2025 2026 2027
Revenue
YoY % growth
OCX revenue by date.OCX revenue by date.
960K
-56.36%		1.503M
56.56%		1.881M
25.15%		3.075M
63.48%		4.444M
44.52%		13.332M
200.00%
EBITDA
YoY % growth
OCX ebitda by date.OCX ebitda by date.
7.41M
115.74%		-14.826M
-300.08%		-17.408M
-17.42%		-20.806M
-19.52%		-24.846M
-19.42%		-21.816M
12.20%
EBIT
YoY % growth
OCX ebit by date.OCX ebit by date.
2.19M
104.27%		-16.506M
-853.70%		-18.972M
-14.94%		-25.103M
-32.31%		-24.695M
1.63%		-21.816M
11.66%
Operating Margin
OCX operating margin by date.OCX operating margin by date.
228.13%-1,098.20%-1,008.61%-816.34%-555.68%-163.64%
EPS
YoY % growth
OCX eps by date.OCX eps by date.
-13.20
-2,900.00%		-3.60
72.73%		-4.40
-22.22%		-0.96
78.19%		-0.95
0.70%		-0.84
12.01%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth		-0.23
35.47%		-0.24
75.95%		-0.23
87.96%		-0.24
9.10%		-0.34
-48.48%		-0.33
-39.50%		-0.31
-34.13%
Revenue
Q2Q % growth		174.397K
67.69%		214.12K
86.19%		214.12K
-85.59%		707K
-66.93%		909K
421.23%		1.111M
418.87%		1.414M
560.38%
EBITDA
Q2Q % growth		-6.767M
-70.41%		-6.767M
45.92%		-6.767M
-168.79%		N/AN/AN/AN/A
EBIT
Q2Q % growth		-6.238M
-34.68%		-6.348M
53.03%		-6.289M
-176.01%		-5.959M
12.35%		-5.151M
17.43%		-4.848M
23.62%		-4.545M
27.73%

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

OCX Yearly Revenue VS EstimatesOCX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 2M 4M 6M 8M 10M
OCX Yearly EPS VS EstimatesOCX Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 -2 -4 -6 -8 -10

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
21.86%
EPS Next 5 Year
N/A

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
197.76%
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
10.61%
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ONCOCYTE CORP / OCX Forecast FAQ

What do analysts expect the price target to be for ONCOCYTE CORP (OCX)?

8 analysts have analysed OCX and the average price target is 5.53 USD. This implies a price increase of 72.66% is expected in the next year compared to the current price of 3.2.

What is the next earnings date for OCX stock?

ONCOCYTE CORP (OCX) will report earnings on 2025-08-06, before the market open.

Can you provide the consensus estimates for ONCOCYTE CORP next earnings?

The consensus EPS estimate for the next earnings of ONCOCYTE CORP (OCX) is -0.23 USD and the consensus revenue estimate is 174.40K USD.

How many analysts have analysed ONCOCYTE CORP (OCX)?

The number of analysts covering ONCOCYTE CORP (OCX) is 8.